The english version of the website is under development. Wherever text appears in Greek, it means it has not been translated yet.

Publications

Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.

Export 369 results:
Author [ Title(Desc)] Type Year
Filters: Author is Polyzos, Stergios A  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
A
Polyzos, S. A., Hawa G., Jungwirth T., Karabouta Z., & Kountouras J. (2019).  Asporin levels are low in patients with nonalcoholic fatty liver disease and increase after vitamin E treatment.. Hormones (Athens).
Doulberis, M., Papaefthymiou A., Polyzos S. A., Bargiotas P., Liatsos C., Srivastava D. Shiva, et al. (2020).  Association between Active Infection and Glaucoma: A Systematic Review and Meta-Analysis.. Microorganisms. 8(6), 
Polyzos, S. A., Kountouras J., Anastasilakis A. D., Margouta A., & Mantzoros C. S. (2015).  Association between circulating irisin and homocysteine in patients with nonalcoholic fatty liver disease.. Endocrine. 49(2), 560-2.
Kountouras, J., Zavos C., Polyzos S. A., Katsinelos P., & Deretzi G. (2015).  Association between cirrhosis and Helicobacter pylori-related brain pathologies.. Eur J Gastroenterol Hepatol. 27(2), 183.
Zavos, C., Kountouras J., Katsinelos P., Polyzos S. A., Deretzi G., Zavos N., et al. (2011).  Association between Helicobacter pylori infection and fibromyalgia syndrome.. Clin Rheumatol. 30(2), 301-2.
Polyzos, S. A., Kountouras J., Zavos C., & Deretzi G. (2011).  The association between Helicobacter pylori infection and insulin resistance: a systematic review.. Helicobacter. 16(2), 79-88.
Vachliotis, I. D., Vasiloglou M. F., Kapama A., Matsagkos D., Goulas A., Papaioannidou P., et al. (2022).  Association between hepatic steatosis and fibrosis indices and dietary habits, physical activity, and quality of life.. Arab J Gastroenterol.
Doulberis, M., Kountouras J., Stadler T., Meerwein C., Polyzos S. A., Kulaksiz H., et al. (2023).  Association between Infection and Nasal Polyps: A Systematic Review and Meta-Analysis.. Microorganisms. 11(6), 
Anastasilakis, A. D., Polyzos S. A., Savvidis M., Anastasilakis D. A., Sarridimitriou A., Kumar A., et al. (2023).  Association of activins, follistatins and inhibins with incident hip fracture in women with postmenopausal osteoporosis: a proof of concept, case-control study.. Endocrine. 81(3), 573-578.
Efstathiadou, Z. A., Sakka C., Polyzos S. A., Goutou M., Stakias N., Bargiota A., et al. (2015).  Associations of estrogen receptor alpha and Beta gene polymorphisms with lipid levels and insulin resistance in men.. Metabolism. 64(5), 611-7.
Anastasilakis, D. A., Makras P., Polyzos S. A., & Anastasilakis A. D. (2019).  Asymptomatic and normocalcemic hyperparathyroidism, the silent attack: a combo-endocrinology overview.. Hormones (Athens). 18(1), 65-70.
Kountouras, J., Papaefthymiou A., Polyzos S. A., Vardaka E., Kyrailidi F., Mouratidou M. C., et al. (2023).  Autonomic Dysfunction and Somatization in Young Patients With Irritable Bowel Syndrome and Mitral Valve Prolapse Syndrome.. J Neurogastroenterol Motil. 29(3), 403-404.
C
Kountouras, J., Polyzos S. A., Katsinelos P., Zeglinas C., Artemaki F., Tzivras D., et al. (2017).  Cardio-cerebrovascular disease and Helicobacter pylori-related metabolic syndrome: We consider eradication therapy as a potential cardio-cerebrovascular prevention strategy.. Int J Cardiol. 229, 17-18.
Polyzos, S. A., & Kountouras J. (2019).  CHAI and MACK-3 as noninvasive indices for nonalcoholic steatohepatitis.. Liver Int.
Polyzos, S. A., Xanthopoulos K., & Kountouras J. (2021).  Cilofexor for the Treatment of Nonalcoholic Steatohepatitis. Curr Vasc Pharmacol.
Tontikidou, C., Makri E. S., Evripidou K., Goulis D. G., Goulas A., & Polyzos S. A. (2022).  Circulating adiponectin in patients with nonalcoholic fatty liver disease-related liver fibrosis: A systematic review and a meta-analysis.. J Gastroenterol Hepatol.
Makri, E., Orfanidou M., Makri E. S., Goulas A., Terpos E., & Polyzos S. A. (2024).  Circulating Ferritin in Patients with Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-analysis.. J Clin Exp Hepatol. 14(3), 101353.
Dalamaga, M., Polyzos S. A., Karmaniolas K., Chamberland J., Lekka A., Migdalis I., et al. (2014).  Circulating fetuin-A in patients with pancreatic cancer: a hospital-based case-control study.. Biomarkers. 19(8), 660-6.
Anastasilakis, A. D., Polyzos S. A., Skouvaklidou E. C., Kynigopoulos G., Saridakis Z. G., Apostolou A., et al. (2016).  Circulating follistatin displays a day-night rhythm and is associated with muscle mass and circulating leptin levels in healthy, young humans.. Metabolism. 65(10), 1459-65.
Polyzos, S. A., Kountouras J., & Tsoukas M. A. (2015).  Circulating homocysteine in nonalcoholic fatty liver disease.. Eur J Intern Med. 26(2), 152-3.
Anastasilakis, A. D., Polyzos S. A., Saridakis Z. G., Kynigopoulos G., Skouvaklidou E. C., Molyvas D., et al. (2014).  Circulating irisin in healthy, young individuals: day-night rhythm, effects of food intake and exercise, and associations with gender, physical activity, diet, and body composition.. J Clin Endocrinol Metab. 99(9), 3247-55.
Anastasilakis, A. D., Koulaxis D., Kefala N., Polyzos S. A., Upadhyay J., Pagkalidou E., et al. (2017).  Circulating irisin levels are lower in patients with either stable coronary artery disease (CAD) or myocardial infarction (MI) versus healthy controls, whereas follistatin and activin A levels are higher and can discriminate MI from CAD. Metabolism. 73, 1-8.

Pages

Contact

Secretariat of the School of Medicine
 

Connect

School of Medicine's presence in social networks
Follow Us or Connect with us.